RxDoctor Payments Data

David Nelson, MD

Family Medicine · Houston, TXNPI 1396752259

Payments from drug & device makers

$6,784in general payments, 2019–2025

Across 405 payments — averaging $16.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$996
  • AbbVie$828
  • AstraZeneca$616
  • Pfizer$477
  • GSK$410
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$400
  • plus $3K from 37 others

What the payments were for

  • Food & beverage$6,784100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,784 in reported general payments places this provider in the 85th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$128,812
Medicare patients
370
Services billed
3,293

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide149$170,251
FarxigaDapagliflozin Propanediol26$39,162
JanuviaSitagliptin Phosphate27$30,797
EliquisApixaban23$24,605
TradjentaLinagliptin34$24,038
XareltoRivaroxaban17$22,668
TrulicityDulaglutide11$20,146
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$17,748
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr22$16,343
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$9,401
SymbicortBudesonide/Formoterol Fumarate25$5,942
PaxlovidNirmatrelvir/Ritonavir29$5,454
Atorvastatin Calcium426$4,044
Albuterol Sulfate HfaAlbuterol Sulfate190$3,970
Rosuvastatin Calcium297$3,736

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$996$170,251149 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$616$54,50563 claims
GSKTrelegy Ellipta, Anoro Ellipta$410$34,09141 claims
MerckJanuvia$84$30,79727 claims
PfizerEliquis, Paxlovid$477$30,05852 claims
Boehringer IngelheimTradjenta$109$24,03834 claims
Johnson & JohnsonXarelto$11$22,66817 claims
Lilly USA, LLCTrulicity$320$20,14611 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$31$2,992382 claims
AbbVieSynthroid$828$2,89045 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →